Thursday, May 22, 2014 8:11:08 PM
XXII - David Letterman's Top 10 Reasons to BUY and Hold XXII
10. XXII Institutional road show coming up in 5 major US cities
9. Company is Presenting and doing 1-1s at the LD Micro Conference in LA
8. Ringing of the opening bell on NYSE
7. Potential add into Russell Index (some market cap predictors are ranging from $150-175mil, so we're right on the bubble)
6. Closing of the NASCO acquisition and the company becoming a MSA member and have their own manufacturing facility
5. National distribution of RED SUN® cigarette proprietary brand and manufacturing of other company's MSA brands in their factory
4. Distribute its brands containing 22nd Century’s proprietary tobacco in Europe & Asia where there is a lot of interest in potentially less harmful tobacco products
3. Applications to be filed with the FDA for two types of proprietary modified-risk cigarette candidates
2. This mysterious Botanical Genetics Subsidiary that was buried in the 10Q (plant biotech division of 22nd Century Group. Feel free to speculate as to what the plant is)
and the #1 reason to BUY and Hold XXII is:
1. Future milestone and royalty payments from British American Tobacco (and who knows what could happen one day with all of the consolidation going on in the tobacco industry)
I bet the smart money is buying in front of all of these catalysts from all the day trading sellers. There is a lot to look forward to. Seems like a BUY to me.
10. XXII Institutional road show coming up in 5 major US cities
9. Company is Presenting and doing 1-1s at the LD Micro Conference in LA
8. Ringing of the opening bell on NYSE
7. Potential add into Russell Index (some market cap predictors are ranging from $150-175mil, so we're right on the bubble)
6. Closing of the NASCO acquisition and the company becoming a MSA member and have their own manufacturing facility
5. National distribution of RED SUN® cigarette proprietary brand and manufacturing of other company's MSA brands in their factory
4. Distribute its brands containing 22nd Century’s proprietary tobacco in Europe & Asia where there is a lot of interest in potentially less harmful tobacco products
3. Applications to be filed with the FDA for two types of proprietary modified-risk cigarette candidates
2. This mysterious Botanical Genetics Subsidiary that was buried in the 10Q (plant biotech division of 22nd Century Group. Feel free to speculate as to what the plant is)
and the #1 reason to BUY and Hold XXII is:
1. Future milestone and royalty payments from British American Tobacco (and who knows what could happen one day with all of the consolidation going on in the tobacco industry)
I bet the smart money is buying in front of all of these catalysts from all the day trading sellers. There is a lot to look forward to. Seems like a BUY to me.
Recent XXII News
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
- 22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/20/2026 09:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 04:59:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 07:17:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 01:00:48 PM
- 22nd Century CEO & Chairman Larry Firestone Provides 2025 Year-in-Review Letter to Stockholders • GlobeNewswire Inc. • 01/15/2026 02:00:00 PM
- 22nd Century to Participate in the Needham Annual Growth Conference January 16, 2026 • GlobeNewswire Inc. • 01/12/2026 09:30:00 PM
- 22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less • GlobeNewswire Inc. • 01/06/2026 11:10:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/30/2025 10:19:44 PM
